Paraplegia following intrathecal chemotherapy neuropathologic findings and elevation of myelin basic protein
Open Access
- 1 July 1982
Abstract
An 11‐year‐old boy developed a severe myelopathy after an eight‐year history of acute lymphoblastic leukemia and numerous courses of intrathecal chemotherapy. Myelin basic protein in the cerebrospinal fluid (CSF) was elevated. Neuropathologic examination disclosed extensive microvacuolar changes in the white matter of the spinal cord. The pathogenesis of myelopathy following intrathecal chemotherapy administered by lumbar puncture includes an early effect on the myelin sheath. Serial assessment of CSF myelin basic protein levels in patients receiving intrathecal chemotherapy may be useful in the early diagnosis of this disorder.This publication has 9 references indexed in Scilit:
- Leukoencephalopathy and Elevated Levels of Myelin Basic Protein in the Cerebrospinal Fluid of Patients with Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1980
- A diagnostic index of active demyelination: Myelin basic protein in cerebrospinal fluidAnnals of Neurology, 1980
- Paraparesis following intrathecal cytosine arabinoside.A case report with neuropathologic findingsCancer, 1977
- Paraplegia following intrathecal methotrexate.Report of a case and review of the literatureCancer, 1976
- Neuropathologic Effects of Intrathecal WaterJournal of Neuropathology and Experimental Neurology, 1975
- Neurotoxicity and Elevated Cerebrospinal-Fluid Methotrexate Concentration in Meningeal LeukemiaNew England Journal of Medicine, 1973
- Paraplegia following intrathecal chemotherapyCancer, 1972
- INTRATHECAL METHOTREXATEThe Lancet, 1969
- Neurological Lesions in Cats Following Cerebrospinal Fluid Manipulation1*Journal of Neuropathology and Experimental Neurology, 1957